In recent years, the rising concern over antibiotic consumption and the consequent development of antimicrobial resistance has prompted extensive research across the globe. A groundbreaking study published in the 2026 issue of BMC Pharmacology and Toxicology sheds light on this phenomenon by investigating the consumption patterns of systemic antibiotics in a tertiary care hospital located in Northern Sri Lanka. This comprehensive five-year trend analysis meticulously examines how antibiotic use has evolved, providing critical insights into prescribing behaviors, potential drivers of antibiotic resistance, and public health implications within a resource-limited setting.
The research, led by Guruparan, Meenadchisundaram, Amarasingam, and their colleagues, offers an unprecedented longitudinal perspective spanning half a decade — a timeframe that allows for the identification of gradual shifts in antibiotic utilization and the effectiveness of interventions or policy changes. At a tertiary care hospital that serves a large population in Northern Sri Lanka, the study leveraged hospital pharmacy records, patient treatment data, and microbiological reports to quantify and qualify systemic antibiotic consumption. The emphasis on systemic antibiotics is notable because these drugs represent the frontline defense in managing serious infections and are integral to modern medical therapeutics.
Through rigorous data collection and sophisticated analytical methods, the authors mapped out the types and volumes of antibiotics used annually, correlating them with patient demographics and infection profiles. Their approach enabled differentiation between broad-spectrum and narrow-spectrum antibiotics, shedding light on prescribing preferences and possible overuse or misuse scenarios. A crucial part of the research involved assessing the consumption trends relative to global guidelines and local antimicrobial stewardship initiatives. The results also provided indirect insights into the evolving burden of infectious diseases in the region and indicated pressures on the healthcare system to manage complex infections.
One of the pivotal findings revealed a fluctuating yet overall increasing trend in the use of broad-spectrum antibiotics within the hospital over the five-year period. This rise is particularly alarming given the well-documented link between indiscriminate broad-spectrum antibiotic usage and the accelerated development of resistant pathogens. The researchers underscored that while broad-spectrum usage may sometimes be clinically justified, especially in critical care settings, the apparent upward trajectory called for more stringent control measures. This trend mirrored global patterns reported in various low- and middle-income countries, highlighting a universal challenge yet underscoring the importance of localized data to inform tailored interventions.
The study detailed various classes of antibiotics, with beta-lactams, macrolides, and fluoroquinolones dominating the consumption chart. Notably, the consumption of carbapenems, often reserved as antibiotics of last resort, saw a concerning increase. The escalation in carbapenem use signals either a rising rate of multidrug-resistant infections or, alternatively, premature escalation in therapy that might be avoidable. The authors emphasized that such trends demand urgent action to steward the judicious use of these critical drugs, involving enhanced diagnostic capabilities to accurately identify resistant infections and optimize treatment regimens.
Importantly, the research also illuminated seasonal variations in antibiotic use, with spikes correlating with periods of increased respiratory infections and hospital admissions. This seasonality suggests that antibiotic prescribing is closely aligned with infection patterns but also raises questions about potential overprescription during high-demand periods. The hospital’s epidemiological data indicated that viral infections, often not requiring antibiotics, were prevalent during these spikes, pointing toward possible unnecessary antibiotic use and catalyzing calls for improved diagnostic stewardship.
The implications of these findings are profound for both clinical practice and public health policy. The authors advocate for the establishment of robust antimicrobial stewardship programs (ASPs) in tertiary institutions across Sri Lanka and comparable settings. Such programs integrate guidelines, prescriber education, and real-time monitoring to ensure antibiotics are used appropriately. The study also recommends investment in laboratory infrastructure to provide rapid and accurate microbiological diagnostics which are vital for targeted therapy and reducing empirical broad-spectrum use.
Moreover, this long-term trend analysis offers policymakers a data-driven foundation to formulate national action plans against antimicrobial resistance (AMR). Given that AMR presents a clear risk not only to individual patients but also to the efficacy of health systems at large, such evidence-based policy frameworks are critical. The authors suggest continuous surveillance systems that track antibiotic consumption alongside resistance patterns to detect emerging threats early and enforce necessary containment strategies.
The public health dimensions of antibiotic consumption also extend to community awareness and behavioral change. The study’s context—a tertiary care hospital in a region where antibiotic access outside hospital settings is common and often unregulated—underscores the need for outreach programs. These programs would educate patients and caregivers about the dangers of inappropriate antibiotic use and encourage adherence to prescribed treatments to prevent selection of resistant strains.
Furthermore, the research highlights challenges faced in low-resource settings, such as data limitations, lack of rapid diagnostics, and constrained antimicrobial stewardship capabilities. Despite these hurdles, the study’s comprehensive methodology sets a benchmark for similar institutions aiming to understand and manage antibiotic use better. This regional study adds valuable nuance to the global narrative on AMR, emphasizing the heterogeneity of antibiotic consumption patterns and the necessity of context-specific strategies.
The study also touches on the economic implications of antibiotic resistance. Increased consumption of higher-generation antibiotics and prolonged hospital stays due to resistant infections strain hospital budgets and national healthcare spending. By identifying consumption trends and potential misuse, the research indirectly points toward cost-saving opportunities through better antibiotic management.
Innovative approaches such as integrating electronic health records with antibiotic prescribing analytics, implementing rapid molecular diagnostics, and fostering interdisciplinary collaboration between microbiologists, pharmacists, and clinicians come highly recommended. These strategies aim to optimize patient care while preserving antibiotic efficacy, which is essential for future preparedness against emerging infections and potential pandemics.
Finally, the study presents a clarion call to the global scientific and medical community. The data from Northern Sri Lanka exemplify the urgent need for comprehensive antibiotic consumption surveillance worldwide, particularly in regions vulnerable to rapid AMR emergence. By providing solid empirical evidence, the research empowers efforts toward a coordinated, strategic response against one of the most pressing threats to global health security.
In sum, the “Consumption of systemic antibiotics in a tertiary care hospital in Northern Sri Lanka: a five-year trend analysis” is a landmark investigation that not only quantifies antibiotic use in a resource-limited hospital setting but also offers critical insights into the complex dynamics shaping antibiotic prescribing trends. The study’s revelations emphasize the delicate balance between effective infection management and stewardship, highlighting areas for urgent intervention and paving the way for systemic improvements in healthcare delivery and policy formulation. This research stands as a vital contribution to the ongoing battle against antibiotic resistance, reinforcing the indispensable role of surveillance, stewardship, and education in safeguarding the future of antimicrobial therapy.
Subject of Research: Consumption and trend analysis of systemic antibiotics in a tertiary care hospital setting, focusing on antimicrobial resistance implications.
Article Title: Consumption of systemic antibiotics in a tertiary care hospital in Northern Sri Lanka: a five-year trend analysis.
Article References:
Guruparan, Y., Meenadchisundaram, P., Amarasingam, S. et al. Consumption of systemic antibiotics in a tertiary care hospital in Northern Sri Lanka: a five-year trend analysis. BMC Pharmacol Toxicol (2026). https://doi.org/10.1186/s40360-026-01169-1
Image Credits: AI Generated
